Fauci Awards Package (Redacted) — page 59
of 136 pages
← p.58 p.60 → · this page in the original PDF · package
phone:
I mobile:
I email:
@nih.gov
https://www.niaid.nih.gov/about/vrc
From: "Mascola, John (NIH/VRC) [E]" <
@mail.nih.gov>
Date: Monday, March 1, 2021 at 9:37 PM
To: "Koup, Richard (NIH/VRC) [E]" <
@mail.nih.gov>, "Graham, Barney (NIH/VRC) [E]"
<
@mail.nih.gov>, "Ledgerwood, Julie (NIH/NIAID) [E]" <
@nih.gov>, Karin Bok
@nih.gov>
Cc: "Sitar, Sandra (NIH/VRC) [C]" <
@mail.nih.gov>
Subject: FW: -
FYI. We should each review and then discuss.
Thanks,
John
From: Fauci, Anthony (NIH/NIAID) [E] <
@niaid.nih.gov>
Sent: Monday, March 1, 2021 6:07 PM
To: Mascola, John (NIH/VRC) [E] <
@mail.nih.gov>
Cc: Lane, Cliff (NIH/NIAID) [E] <
@niaid.nih.gov>
Subject: FW: -
Let us discuss.
Anthony S. Fauci, MD
Director
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, MD
Phone:
FAX:
E-mail:
@niaid.nih.gov
The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It
should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error
please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of
Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's
own and not expressly made on behalf of the NIAID by one of its representatives.
From: Weissman, Drew <
@pennmedicine.upenn.edu>
Sent: Monday, March 1, 2021 5:21 PM
To: Fauci, Anthony (NIH/NIAID) [E] <
@niaid.nih.gov>
Subject: Re: -
Tony,
Here is the human dose IM studies in pregnant mice. We still have some concern over the data and are talking to all of the
appropriate people.
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/fauci_awards/59
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| Re: - | 2021-03-01 | 59–60 | |
| FW: - | 2021-03-01 | 59 | |
| FW: - | 2021-03-01 | 59 | |
| FW: - | 2021-03-02 | 58–59 |